Market revenue in 2023 | USD 19.1 million |
Market revenue in 2030 | USD 37.9 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 56.54% in 2023. Horizon Databook has segmented the Spain deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Spain deep brain stimulation devices market is primarily driven by the rising incidence of neurological disorders such as epilepsy and PD in this country. According to FEEN report, around 400,000 people were living with epilepsy in Spain as of 2017.
Similarly, according to NCBI, around 300,000 people are living with PD in Spain. Furthermore, increase in research activities for developing advanced deep brain stimulation devices is expected to boost the market growth.
For instance, in September 2017 the University Hospital of Bellvitge performed MRI for the first time of an OCD patient with deep brain stimulation devices. In addition, increasing healthcare expenditure is expected to drive the market growth. For instance, in 2018, Spain spent USD 3,323 per capita on healthcare.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account